| Title | Hematological Oncology |
| Abbreviation | Hematol. Oncol. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Hematology (Q1); Medicine (miscellaneous) (Q1); Cancer Research (Q2); Oncology (Q2) |
| h-index | 57 |
| Overall Rank/Ranking | 4614 |
| SCImago Journal Rank (SJR) | 1.027 |
| Impact Score | 2.43 |
| Publisher | John Wiley and Sons Ltd |
| Country | United Kingdom |
| ISSN | 10991069, 02780232 |
| Best Quartile | Q1 |
| Coverage History | 1983-2025 |
Hematological Oncology is a journal covering the technologies/fields/categories related to Hematology (Q1); Medicine (miscellaneous) (Q1); Cancer Research (Q2); Oncology (Q2). It is published by John Wiley and Sons Ltd. The overall rank of Hematological Oncology is 4614. According to SCImago Journal Rank (SJR), this journal is ranked 1.027. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 57. The best quartile for this journal is Q1.
The ISSN of Hematological Oncology journal is 10991069, 02780232. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Hematological Oncology is cited by a total of 877 articles during the last 3 years (Preceding 2024).
The Impact IF 2024 of Hematological Oncology is 2.43, which is computed in 2025 as per its definition. Hematological Oncology IF is increased by a factor of 0.14 and approximate percentage change is 6.11% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2024 of Hematological Oncology is 2.43. If the same upward trend persists, Impact IF may rise in 2025 as well.
| Year | Impact IF |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 2.43 |
| 2023 | 2.29 |
| 2022 | 2.19 |
| 2021 | 2.97 |
| 2020 | 2.65 |
| 2019 | 2.04 |
| 2018 | 1.66 |
| 2017 | 1.74 |
| 2016 | 1.46 |
| 2015 | 2.22 |
| 2014 | 2.29 |
Hematological Oncology has an h-index of 57. It means 57 articles of this journal have more than 57 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Hematological Oncology is 10991069, 02780232. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Hematological Oncology is 4614. According to SCImago Journal Rank (SJR), this journal is ranked 1.027. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 1.027 |
| 2023 | 0.82 |
| 2022 | 1.051 |
| 2021 | 0.971 |
| 2020 | 0.918 |
| 2019 | 0.728 |
| 2018 | 0.650 |
| 2017 | 0.605 |
| 2016 | 0.658 |
| 2015 | 0.794 |
| 2014 | 0.993 |
| Year | Ranking |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 4614 |
| 2023 | 6001 |
| 2022 | 3885 |
| 2021 | 4280 |
| 2020 | 4981 |
| 2019 | 6665 |
| 2018 | 7422 |
| 2017 | 7789 |
| 2016 | 7199 |
| 2015 | 5978 |
| 2014 | 4383 |
Hematological Oncology is published by John Wiley and Sons Ltd. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 1983-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Hematological Oncology is Hematol. Oncol.. This abbreviation ('Hematol. Oncol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Hematology (Q1); Medicine (miscellaneous) (Q1); Cancer Research (Q2); Oncology (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Hematological Oncology latest impact IF is 2.43. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 2.97 (2021) and 1.46 (2016), respectively, in the last 11 years. Moreover, its average IS is 2.18 in the previous 11 years.
The Hematological Oncology has an SJR (SCImago Journal Rank) of 1.027, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 1.051 in 2022 and the lowest being 0.605 in 2017. Furthermore, the average SJR of the Hematological Oncology over the previous 11-year period stands at 2.18.
The latest h-index of the Hematological Oncology is 57.
The Hematological Oncology is published by the John Wiley and Sons Ltd, with its country of publication being the United Kingdom.
The Hematological Oncology is currently ranked 4614 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 3885 in 2022 and its lowest position of 7789 in 2017.
The standard ISO4 abbreviation for the Hematological Oncology is Hematol. Oncol..
Hematological Oncology is classified as a journal that the John Wiley and Sons Ltd publishes.
The Hematological Oncology encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Hematological Oncology is assigned the following International Standard Serial Numbers (ISSN): 10991069, 02780232.
The best quartile for the Hematological Oncology is Q1 (2024).
The Hematological Oncology coverage history can be summarized as follows: 1983-2025.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| CESifo Economic Studies | journal | 17776 | Oxford University Press | 36 | 0.89 |
| Journal of Business Finance and Accounting | journal | 3244 | Wiley-Blackwell Publishing Ltd | 96 | 3.34 |
| Business Strategy Review | journal | 31512 | Wiley-Blackwell Publishing Ltd | 33 | 0.04 |
| International Journal of Mathematical Education in Science and Technology | journal | 6477 | Taylor and Francis Ltd. | 45 | 1.82 |
| Materials Research | journal | 15597 | Universidade Federal de Sao Carlos | 75 | 1.40 |
| European Surgery - Acta Chirurgica Austriaca | journal | 18136 | Springer Medizin | 25 | 0.68 |
| Korean Journal of Applied Microbiology and Biotechnology | journal | 22033 | Korean Society for Applied Microbiology | 0 | 0.00 |
| Statistica | journal | 18529 | University of Bologna | 9 | 0.38 |
| Population Review | journal | 19550 | Sociological Demography Press | 15 | 0.59 |
| Proceedings of the Royal Society of Queensland | journal | 28017 | Royal Society of Queensland | 12 | 0.17 |
| Year | Impact Score (IS) |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 2.43 |
| 2023 | 2.29 |
| 2022 | 2.19 |
| 2021 | 2.97 |
| 2020 | 2.65 |
| 2019 | 2.04 |
| 2018 | 1.66 |
| 2017 | 1.74 |
| 2016 | 1.46 |
| 2015 | 2.22 |
| 2014 | 2.29 |
